On May 30, 2018 Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, reported that members of the management team will participate in two upcoming investor conferences (Press release, Syndax, MAY 30, 2018, View Source [SID1234526975]). The details for the two conferences are:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies 2018 Global Healthcare Conference in New York on Wednesday, June 6, 2018. Corporate presentation at 4:30 pm ET.

JMP Securities Life Sciences Conference at the St. Regis New York on Wednesday, June 20, 2018. Panel discussion at 3:30 pm ET.
A live webcast of the Jefferies 2018 Global Healthcare Conference presentation can be accessed from the Investor section of the Company’s website at www.syndax.com, where a replay of the events will also be available for a limited time.